New drug MTX-101 tested in humans for first time – could it tame type 1 diabetes?
NCT ID NCT06324604
First seen Mar 28, 2026 · Last updated Jun 12, 2026 · Updated 11 times
Summary
This early-stage study tests a new drug called MTX-101 in healthy adults and people with type 1 diabetes. The main goal is to see if it is safe, how long it stays in the body, and how it affects immune cells. About 96 participants will receive single or multiple doses to gather this safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Health
RECRUITINGHeidelberg, Victoria, 3084, Australia
Contact
-
St Vincent's Hospital Melbourne (SVHM)
RECRUITINGFitzroy, 3065, Australia
Contact
-
The Royal Melbourne Hospital
RECRUITINGMelbourne, Victoria, 3050, Australia
Contact
Conditions
Explore the condition pages connected to this study.